Yoshimi Kakiuchi

730 total citations
23 papers, 630 citations indexed

About

Yoshimi Kakiuchi is a scholar working on Pharmacology, Surgery and Molecular Biology. According to data from OpenAlex, Yoshimi Kakiuchi has authored 23 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Yoshimi Kakiuchi's work include Inflammatory mediators and NSAID effects (8 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Gastroesophageal reflux and treatments (4 papers). Yoshimi Kakiuchi is often cited by papers focused on Inflammatory mediators and NSAID effects (8 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Gastroesophageal reflux and treatments (4 papers). Yoshimi Kakiuchi collaborates with scholars based in Japan and United States. Yoshimi Kakiuchi's co-authors include Masahiko Tsujii, Shingo Tsuji, Masakazu Yasumaru, Sunao Kawano, Naoki Kawai, Arata Kimura, Yutaka Sasaki, Norio Hayashi, Masato Komori and Takanobu Irie and has published in prestigious journals such as Gastroenterology, Journal of Pharmacology and Experimental Therapeutics and International Journal of Cancer.

In The Last Decade

Yoshimi Kakiuchi

22 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshimi Kakiuchi Japan 13 208 183 161 122 107 23 630
Masakazu Yasumaru Japan 16 188 0.9× 161 0.9× 201 1.2× 117 1.0× 122 1.1× 31 728
Takanobu Irie Japan 10 124 0.6× 123 0.7× 83 0.5× 89 0.7× 105 1.0× 14 444
Kenji Hatano Japan 9 247 1.2× 144 0.8× 132 0.8× 72 0.6× 163 1.5× 14 743
Lia Guidotti Italy 16 152 0.7× 378 2.1× 89 0.6× 189 1.5× 59 0.6× 27 964
Farhat V. N. Din United Kingdom 8 171 0.8× 230 1.3× 100 0.6× 92 0.8× 78 0.7× 14 690
Gerasimos P. Vandoros Greece 14 87 0.4× 353 1.9× 138 0.9× 67 0.5× 211 2.0× 24 797
Lucia Picariello Italy 17 71 0.3× 277 1.5× 172 1.1× 145 1.2× 496 4.6× 24 976
Atsushi Kawabe Japan 15 79 0.4× 270 1.5× 174 1.1× 123 1.0× 46 0.4× 24 643
Naokuni Tatsumoto Japan 13 41 0.2× 417 2.3× 175 1.1× 145 1.2× 94 0.9× 33 1.2k
Bastiaan P. van Rees Netherlands 15 407 2.0× 171 0.9× 467 2.9× 51 0.4× 235 2.2× 20 949

Countries citing papers authored by Yoshimi Kakiuchi

Since Specialization
Citations

This map shows the geographic impact of Yoshimi Kakiuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshimi Kakiuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshimi Kakiuchi more than expected).

Fields of papers citing papers by Yoshimi Kakiuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshimi Kakiuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshimi Kakiuchi. The network helps show where Yoshimi Kakiuchi may publish in the future.

Co-authorship network of co-authors of Yoshimi Kakiuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshimi Kakiuchi. A scholar is included among the top collaborators of Yoshimi Kakiuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshimi Kakiuchi. Yoshimi Kakiuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Egawa, Satoshi, Hideki Iijima, Shinichiro Shinzaki, et al.. (2008). Upregulation of GRAIL is associated with remission of ulcerative colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 295(1). G163–G169. 12 indexed citations
2.
Nishida, Tsutomu, Shingo Tsuji, Masahiko Tsujii, et al.. (2008). Cultured bone marrow cell local implantation accelerates healing of ulcers in mice. Journal of Gastroenterology. 43(2). 124–135. 11 indexed citations
3.
Shinzaki, Shinichiro, Hideki Iijima, Takatoshi Nakagawa, et al.. (2008). IgG Oligosaccharide Alterations Are a Novel Diagnostic Marker for Disease Activity and the Clinical Course of Inflammatory Bowel Disease. The American Journal of Gastroenterology. 103(5). 1173–1181. 64 indexed citations
4.
Shinzaki, Shinichiro, Hideki Iijima, Takatoshi Nakagawa, et al.. (2008). S1179 IgG Oligosaccharide Alterations Are a Novel Diagnostic Marker for Disease Activity and the Clinical Course of Inflammatory Bowel Disease. Gastroenterology. 134(4). A–195. 2 indexed citations
5.
Irie, Takanobu, Masahiko Tsujii, Shingo Tsuji, et al.. (2007). Synergistic antitumor effects of celecoxib with 5‐fluorouracil depend on IFN‐γ. International Journal of Cancer. 121(4). 878–883. 36 indexed citations
6.
Izumi, Yuko, Naoki Hiramatsu, Ichiyo Itose, et al.. (2005). Juvenile hepatocellular carcinoma with congestive liver cirrhosis. Journal of Gastroenterology. 40(2). 204–208. 18 indexed citations
7.
Inoue, Takahiro, Naoki Hiramatsu, Tsutomu Nishida, et al.. (2004). Successful hepatic arterial infusion chemotherapy of cisplatin in advanced hepatocellular carcinoma. Kanzo. 45(9). 499–504. 4 indexed citations
8.
Kakiuchi, Yoshimi, et al.. (2004). Circulating soluble Fas levels in patients with hepatitis C virus infection and interferon therapy. Journal of Gastroenterology. 39(12). 1189–1195. 4 indexed citations
9.
Irie, Takanobu, Masahiko Tsujii, Masato Komori, et al.. (2003). Effects of non-steroidal anti-inflammatory drugs (NSAIDs) with 5-fluorouracil in colon cancer. Gastroenterology. 124(4). A57–A57. 1 indexed citations
10.
Yasumaru, Masakazu, Shingo Tsuji, Masahiko Tsujii, et al.. (2003). Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.. PubMed. 63(20). 6726–34. 62 indexed citations
11.
Yasumaru, Masakazu, Shingo Tsuji, Masahiko Tsujii, et al.. (2003). Inhibition of angiotensin II activity enhanced the anti-tumor effect of cyclooxygenase-2 inhibitors Via insulin-like growth factor I receptor pathway. Gastroenterology. 124(4). A57–A57. 24 indexed citations
12.
Yuki, Nobukazu, Kunimitsu Kawahara, Yoshimi Kakiuchi, et al.. (2002). Histological improvement of chronic liver disease after spontaneous serum hepatitis C virus clearance. Journal of Medical Virology. 69(1). 41–49. 9 indexed citations
13.
Kawai, Naoki, Shingo Tsuji, Masahiko Tsujii, et al.. (2002). Tumor necrosis factor α stimulates invasion of Src-activated intestinal cells. Gastroenterology. 122(2). 331–339. 29 indexed citations
14.
Komori, Masato, Shingo Tsuji, Masahiko Tsujii, et al.. (2002). Gastrin enhances gastric mucosal integrity through cyclooxygenase-2 upregulation in rats. American Journal of Physiology-Gastrointestinal and Liver Physiology. 283(6). G1368–G1378. 29 indexed citations
15.
Tsuji, Shingo, Masahiko Tsujii, Naoki Kawai, et al.. (2002). Lansoprazole Induces Mucosal Protection through Gastrin Receptor-Dependent Up-Regulation of Cyclooxygenase-2 in Rats. Journal of Pharmacology and Experimental Therapeutics. 303(3). 1301–1308. 38 indexed citations
16.
Kawai, Naoki, Shingo Tsuji, Masahiko Tsujii, et al.. (2001). Influence of TNF-α on the gene expression profile in src transtormed intestinal epithelial cells. Gastroenterology. 120(5). A300–A300. 1 indexed citations
17.
Sun, Wei‐Hao, Shingo Tsuji, Masahiko Tsujii, et al.. (2000). Induction of Cyclooxygenase-2 in Rat Gastric Mucosa by Rebamipide, a Mucoprotective Agent. Journal of Pharmacology and Experimental Therapeutics. 295(2). 447–452. 72 indexed citations
18.
Sun, Wei‐Hao, Shingo Tsuji, Masahiko Tsujii, et al.. (2000). Cyclo‐oxygenase‐2 inhibitors suppress epithelial cell kinetics and delay gastric wound healing in rats. Journal of Gastroenterology and Hepatology. 15(7). 752–761. 23 indexed citations
19.
Yuki, Nobukazu, Michio Kato, Masato Komori, et al.. (2000). Retreatment with Interferon for Chronic Hepatitis C After Transient Response. Journal of Clinical Gastroenterology. 31(4). 297–301. 4 indexed citations
20.
Kato, Michio, Yoshimi Kakiuchi, Eriko Fujii, et al.. (1998). Thrombotic thrombocytopenic purpura developed suddenly during interferon treatment for chronic hepatitis C. Journal of Gastroenterology. 33(4). 588–592. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masakazu Yasumaru Breakdown of academic impact, for papers by Takanobu Irie Breakdown of academic impact, for papers by Kenji Hatano Breakdown of academic impact, for papers by Lia Guidotti Breakdown of academic impact, for papers by Farhat V. N. Din Breakdown of academic impact, for papers by Gerasimos P. Vandoros Breakdown of academic impact, for papers by Lucia Picariello Breakdown of academic impact, for papers by Atsushi Kawabe Breakdown of academic impact, for papers by Naokuni Tatsumoto Breakdown of academic impact, for papers by Bastiaan P. van Rees
Rankless by CCL
2026